Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Acta Ophthalmologica|November 9, 2017
Efficacy of predetermined therapeutic measures against bleb-related infection in the Collaborative Bleb-related Infection Incidence and Treatment StudyNobuyuki Shoji, Yoshikuni Arakaki, Kenji Nakamoto, et al.Journal of Glaucoma|March 19, 2019
Frequencies of 4 Distinct Patterns of Glaucomatous Disc Appearance and Their Clinical Associations in Japanese Population-based StudiesAiko Iwase, Makoto Araie, Yasuaki Kuwayama, et al.Nippon Ganka Gakkai Zasshi|January 5, 2013
[Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy]Makoto Araie, Yoshio Yamazaki, Kazuhisa Sugiyama, et al.JAMA Ophthalmology|June 22, 2013
Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, et al.Nippon Ganka Gakkai Zasshi|October 9, 2003
[Effects of ocular hypotensive agents on the circadian rhythm in intraocular pressure in rabbits as measured by telemetry]Takahiro Akaishi, Atsushi Shimazaki, Takeshi Matsugi, et al.American Journal of Ophthalmology|July 9, 2013
Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertensionHidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 15, 2022
Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL StudyDavid L Wirta, Yasuaki Kuwayama, Fenghe Lu, et al.Acta Ophthalmologica|December 10, 2014
Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover studyHidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, et al.Acta Ophthalmologica|May 10, 2016
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin CKenji Kashiwagi, Satoshi Kogure, Fumihiko Mabuchi, et al.JAMA Ophthalmology|April 17, 2015
Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical TrialsHidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, et al.Pageof 5